[1]李莉莎,王凤婵.麻杏石甘汤调控TLR4/NF-κB信号通路治疗慢性阻塞性肺疾病的机制[J].西部中医药,2023,36(04):7-11.[doi:10.12174/j.issn.2096-9600.2023.04.02]
　LI Lisha,WANG Fengchan.The Mechanism of Maxing Shigan Decoction in the Treatment of Chronic Obstructive Pulmonary Disease by Regulating TLR4/NF-κB Signaling Pathway[J].Western Journal of Traditional Chinese Medicine,2023,36(04):7-11.[doi:10.12174/j.issn.2096-9600.2023.04.02]
点击复制

麻杏石甘汤调控TLR4/NF-κB信号通路治疗慢性阻塞性肺疾病的机制
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
36
期数:
2023年04期
页码:
7-11
栏目:
出版日期:
2023-04-15

文章信息/Info

Title:
The Mechanism of Maxing Shigan Decoction in the Treatment of Chronic Obstructive Pulmonary Disease by Regulating TLR4/NF-κB Signaling Pathway
作者:
李莉莎, 王凤婵
青岛市中医院,山东 青岛 266033
Author(s):
LI Lisha, WANG Fengchan
Qingdao Hospital of TCM, Qingdao 266033, China
关键词:
阻塞性肺疾病; 慢性; 麻杏石甘汤; TLR4/NF-B信号通路; 炎症; 基质金属蛋白酶9; 大鼠; 动物实验
Keywords:
obstructive pulmonary disease;  chronic; decoction; TLR4/NF-B signaling pathway; inflammation; MMP-9; rats; zoopery
分类号:
R256.1
DOI:
10.12174/j.issn.2096-9600.2023.04.02
文献标志码:
A
摘要:
目的探讨麻杏石甘汤通过调控Toll样受体4（Toll-like receptor 4 polypeptide，TLR4）/核因子-κB（nuclear factor-kappa B，NF-κB）信号通路治疗慢性阻塞性肺疾病（chronic obstructive pulmonary disease，COPD）的机制。 方法将36只SD大鼠随机分成正常组、模型组、治疗组，每组12只。除正常组外，模型组和治疗组采用烟熏联合气管内滴入脂多糖的方法制备COPD大鼠模型。正常组及模型组正常饲养，治疗组予以麻杏石甘汤灌胃治疗，共干预4周。采用肺功能仪检测大鼠肺功能［吸气阻力（inspiratory resistance，Ri）、呼气阻力（respiratory resistance，Re）和肺组织顺应性（dynamic lung compliance，Cdyn）］；采用HE染色观察各组肺组织形态；采用Western blot检测基质金属蛋白酶9（matrix metalloproteinases-9，MMP-9）、TLR4、NF-κB p65蛋白相对表达量；采用ELISA法检测炎症因子白细胞介素6（interleukin-6，IL-6）和白细胞介素18（interleukin-18，IL-18）的表达。 结果模型组和治疗组Ri、Re显著高于正常组（P＜0.05），Cdyn显著低于正常组（P＜0.05）；治疗组Ri、Re显著低于模型组（P＜0.05），Cdyn显著高于模型组（P＜0.05）。HE染色显示，正常组肺组织结构正常；模型组肺组织中较多炎性粒子浸润，肺组织结构破坏严重；治疗组肺组织形态较模型组明显改善。Western blot显示，模型组和治疗组MMP-9、TLR4、NF-κB p65蛋白相对表达量显著高于正常组（P＜0.05）；治疗组MMP-9、TLR4、NF-κB p65蛋白相对表达量低于模型组（P＜0.05）。ELISA结果显示，模型组和治疗组IL-6和IL-18含量显著高于正常组（P＜0.05），治疗组IL-6和IL-18含量显著低于模型组（P＜0.05）。 结论麻杏石甘汤通过抑制TLR4/NF-κB信号通路，减少炎性细胞浸润及MMP-9的表达，从而改善COPD症状。
Abstract:
ObjectiveTo discuss the mechanism of Maxing Shigan decoction in the treatment of COPD by adjusting TLR4/NF-κB signaling pathway. MethodsA total of 36 SD rats were randomized into the normal group, the model group and the treatment group, 12 rats in each group. Except for the normal group, COPD rat models were established by adopting smoking combined with intratracheal instillation of lipopolysaccharide in the model group and the treatment group. The normal group and the model group were raised by normal forage, and the treatment group accepted oral administration of Maxing Shigan decoction, altogether for four weeks of intervention. Spirometer was adopted to detect lung function (Ri, Re and Cdyn) of the rats; HE staining was used to observe lung histomorphology in different groups; Western blot to measure the relative expressions of MMP-9, TLR4 and NF-κB p65 protein; ELISA to detect the expressions of IL-6 and IL-18. ResultsRi and Re of the model group and the treatment group were higher than these of the normal group (P<0.05), Cdyn lower than that of the normal group remarkably (P<0.05); Ri and Re of the treatment group were lower than these of the model group (P<0.05), Cdyn higher than that of the model group significantly (P<0.05). HE staining displayed that lung structure of the normal group was normal; while more inflammatory particles were infiltrated into lung tissue in the model group, the damage to the lung structure was severe; morphological improvements of lung tissue of the treatment group were more noticeable than these of the model group. Western blot results showed that the relative expressions of MMP-9, TLR4 and NF-κB p65 protein of the model group and the treatment group were higher than these of the normal group apparently (P<0.05); the relative expressions of MMP-9, TLR4 and NF-κB p65 protein of the treatment group were lower than these of the model group (P<0.05). ELISA results showed that the model group and the treatment group were higher than the normal group in the contents of IL-6 and IL-18 (P<0.05), the treatment group was lower than the model group in the contents of IL-6 and IL-18 (P<0.05). ConclusionMaxing Shigan decoction could improve the symptoms of COPD by inhibiting TLR4/NF-κB signaling pathway, reducing inflammatory cell infiltration and the expressions of MMP-9.

相似文献/References:

[1]崔毅.益气活血汤治疗慢性盆腔炎64例临床观察[J].西部中医药,2012,25(12):75.
　CUI Yi.Clinical Observation on YiQi HuoXueTang and Activating Blood Decoction in Treating 64 Cases of Chronic Pelvic Inflammatory Disease[J].Western Journal of Traditional Chinese Medicine,2012,25(04):75.
[2]樊斗霜.枳实消痞丸(汤)合丹参饮加减治疗慢性萎缩性胃炎32例[J].西部中医药,2013,26(02):72.
　FAN Doushuang.Modified ZhiShi XiaoPiWan(Prescription) and DanShenYin in Treating 32 Cases of Chronic Atrophic Gastritis[J].Western Journal of Traditional Chinese Medicine,2013,26(04):72.
[3]尤海鹰.制萎煎治疗脾胃虚弱型慢性萎缩性胃炎40例[J].西部中医药,2013,26(03):84.
　YOU Haiying.ZhiWeiJian in Treating 40 Cases of Chronic Atrophic Gastritis of Spleen-stomach Deficiency Pattern[J].Western Journal of Traditional Chinese Medicine,2013,26(04):84.
[4]张建平,刘洁,赵志亮.针灸治疗慢性前列腺炎25例疗效观察[J].西部中医药,2013,26(03):111.
　ZHANG Jianping,LIU Jie,ZHAO Zhiliang.Observation on Acupuncture in Treating 25 Cases of Chronic Prostatitis[J].Western Journal of Traditional Chinese Medicine,2013,26(04):111.
[5]魏国俊,郑恒恒,指导：燕中.损伤胶囊与正骨水治疗慢性软组织损伤疗效比较[J].西部中医药,2013,26(11):8.
　WEI Guojun,ZHENG Hengheng,Director: YAN Zhong.The Difference in Clinical Effects between SunShang Capsule and Bonesetting Liquid in Treating Chronic Soft Tissue Injury[J].Western Journal of Traditional Chinese Medicine,2013,26(04):8.
[6]朱建坤,温晓辉,梁玉杰△.敦煌葆元膏对下丘脑-垂体-肾上腺轴作用的实验研究*[J].西部中医药,2013,26(11):13.
　ZHU Jiankun,WEN Xiaohui,LIANG Yujie.Experimental Study on the Effects of DunHuang BaoYuan Ointment on Hypothalamic-pituitary-adrenal Axis[J].Western Journal of Traditional Chinese Medicine,2013,26(04):13.
[7]孙国荣,景克荣,权亚喜.生脉注射液对慢性心衰患者心功能及其心率变异性的影响[J].西部中医药,2013,26(04):68.
　SUN Guorong,JING Kerong,QUAN Yaxi.The Influence of ShengMai Injection on Heart Function and Heart Rate Variability of Patients with Chronic Heart Failure[J].Western Journal of Traditional Chinese Medicine,2013,26(04):68.
[8]俄静,夏小军,杨楠.益气温阳法治疗慢性血小板减少性紫癜经验举隅[J].西部中医药,2013,26(06):58.
　E Jing,XIA Xiaojun,YANG Nan.Invigorating Qi and Yang Method in Treating Chronic Thrombocytopenic Purpura[J].Western Journal of Traditional Chinese Medicine,2013,26(04):58.
[9]马继利.中西药物联用治疗慢性萎缩性胃炎58例[J].西部中医药,2013,26(06):91.
　MA Jili.Treatment for 58 Cases of Chronic Atrophic Gastritis with Integrative Medicines[J].Western Journal of Traditional Chinese Medicine,2013,26(04):91.
[10]延保国.还原型谷胱甘肽联合苦黄注射液治疗慢性乙型肝炎40例疗效观察[J].西部中医药,2012,25(09):68.
　YAN Bao-guo.Curative Observation on Reduced Glutathione for Injection and KuHuang Injection in Treating 40 Cases of Chronic Hepatitis B[J].Western Journal of Traditional Chinese Medicine,2012,25(04):68.
[11]王兰娣,潘文.沙美特罗替卡松联合益气养阴合剂治疗轻症及缓解期COPD36例[J].西部中医药,2012,25(05):76.
　WANG Lan-di,PAN Wen.Treatment for 36 Cases of Chronic Obstructive Pulmonary Disease at Mild and Remission Stages with Salmeterol Fluticasone and Mixture of Replenishing Qi and Nourishing Yin[J].Western Journal of Traditional Chinese Medicine,2012,25(04):76.
[12]许振林,许正龙,贾永兰,等.慢肺饮氧动雾化吸入治疗慢性阻塞性肺疾病137例[J].西部中医药,2013,26(09):5.
　XU Zhenlin,XU Zhenglong,JIA Yonglan,et al.Treatment for 137 Cases of Chronic Obstructive Pulmonary Disease with Oxygen Atomizing Inhalation of ManFei Drink[J].Western Journal of Traditional Chinese Medicine,2013,26(04):5.
[13]李娜,张中新,李双霞.火龙督脉铺灸治疗慢性阻塞性肺疾病稳定期42例[J].西部中医药,2013,26(09):98.
　LI Na,ZHANG Zhongxin,LI Shuangxia.Treating 42 Cases of Chronic Obstructive Pulmonary Disease at Stationary Phase with Fire Dragon Therapy of Long-snake Moxibustion along Governor Meridian[J].Western Journal of Traditional Chinese Medicine,2013,26(04):98.
[14]郑引水,马国义.曲安奈德注射液穴位注射治疗慢性阻塞性肺病急性加重期 35 例[J].西部中医药,2014,27(08):115.
[15]李英梅,刘莉.中医护理对慢性阻塞性肺疾病急性加重期患者的干预效果研究[J].西部中医药,2014,27(10):148.
[16]惠朋利,李英,贺鹏.苏黄止咳胶囊联合噻托溴铵治疗慢性阻塞性肺疾病46例[J].西部中医药,2018,31(12):80.
　HUI Pengli,LI Ying,HE Peng.SuHuang Cough-stopping Capsules and Tiotropium Bromide in Treating 46 Cases of Chronic Obstructive Pulmonary Disease[J].Western Journal of Traditional Chinese Medicine,2018,31(04):80.
[17]陈茜,刘伟,姜华,等.参苓白术散联合氨茶碱片治疗慢性阻塞性肺疾病的临床疗效[J].西部中医药,2020,33(06):95.[doi:10.12174/j.issn.1004-6852.2020.06.25]
　CHEN Xi,LIU Wei,JIANG Hua,et al.A Study on Clinical Effects of Shenling Baizhu Powder Combined with Aminophylline Tablets in Treating COPD[J].Western Journal of Traditional Chinese Medicine,2020,33(04):95.[doi:10.12174/j.issn.1004-6852.2020.06.25]
[18]尹加亮,童佳兵.中药配方颗粒治疗痰热阻肺型慢性阻塞性肺疾病急性加重期患者的有效性和安全性[J].西部中医药,2021,34(06):89.[doi:10.12174/j.issn.2096-9600.2021.06.21]
　YIN Jialiang,TONG Jiabing.Evaluation of the Safety and Effectiveness of Herbal Granules in the Treatment of Acute Exacerbation of COPD of Phlegm-heat Obstracting Lung Pattern[J].Western Journal of Traditional Chinese Medicine,2021,34(04):89.[doi:10.12174/j.issn.2096-9600.2021.06.21]
[19]魏睿,由丽娜,夏杰,等.慢性阻塞性肺疾病中医“寒饮”证患者报告结局量表的信度与效度评价[J].西部中医药,2021,34(02):80.[doi:10.12174/j.issn.2096-9600.2021.02.22]
　WEI Rui,YOU Lina,XIA Jie,et al.Evaluation of Reliability and Validity of CFS-COPD-PRO for COPD patients of "Cold and Fluid" Pattern[J].Western Journal of Traditional Chinese Medicine,2021,34(04):80.[doi:10.12174/j.issn.2096-9600.2021.02.22]
[20]刘海,沈娅妮,刘晓梅,等.五禽戏对稳定期慢性阻塞性肺疾病患者有效性的Meta分析[J].西部中医药,2023,36(02):53.[doi:10.12174/j.issn.2096-9600.2023.02.12]
　LIU Hai,SHEN Yani,LIU Xiaomei,et al.Meta Analysis of the Effectiveness of Wu Qin Xi on Stable COPD Patients[J].Western Journal of Traditional Chinese Medicine,2023,36(04):53.[doi:10.12174/j.issn.2096-9600.2023.02.12]

备注/Memo

备注/Memo:
李莉莎（1975—），女，硕士学位，主任医师。研究方向：呼吸系统疾病的中西医结合诊治。
更新日期/Last Update: 2023-04-15